Emmes Group

Emmes Group has been advancing clinical research and human health for over 40 years; delivering over 2,000 transformative trials, impacting nearly 1 million patients worldwide. By combining Emmes' legacy of clinical excellence, scientific integrity, and trial optimization with Veridix AI's ability to harness cutting-edge technology and data we are improving patient outcomes and revolutionizing clinical research by delivering faster, more efficient clinical trials. Visit https://hubs.la/Q02xgXPy0 to learn more. #CRO #ClinicalResearch #innovation #AI #ClinicalTrials

As the industry’s leading vaccine specialized CRO, VaxTRIALS, part of Emmes Group, is committed to building strong partnerships in vaccine research. With our philosophy of "Global Insight, Local Impact," we specialize in tailored solutions for vaccines and infectious disease trials, driven by passionate experts who consistently deliver proven results. Together with our partners, we're dedicated to navigating the future of clinical research and making a meaningful impact on global healthcare! Together We Make It Possible! #ClinicalTrials #VaccineResearch #InfectiousDiseases #GlobalHealth #CRO

Click here:https://lnkd.in/e9cPhf5x to read about Emmes Group's recent partnership with ILiAD Biotechnologies, LLC to conduct an upcoming Phase III clinical trials of BPZE1, the leading next-generation pertussis vaccine. This partnership underscores our commitment to advancing public health through innovative clinical research. Together, we are excited to contribute to the development of this crucial vaccine.. #ClinicalTrials #PublicHealth #PertussisVaccine #EmmesGroup #ILiADBiotechnologies

"We're honored to support ILiAD's work, which has the potential to significantly reduce transmissibility and incidence of B. pertussis, particularly in vulnerable populations." Sastry Chilukuri, Emmes Group CEO Read more about this partnership here: https://lnkd.in/eJzEKCeR #EmmesGroup #ILiADBiotech #BPZE1 #VaccineDevelopment #ClinicalTrials #WhoopingCough

We’re proud to share that ILiAD Biotechnologies, LLC has selected Emmes Group to conduct their Phase III studies of its lead pertussis vaccine candidate, BPZE1! Our proven expertise in vaccine development through VaxTRIALS, part of EmmesGroup and advanced technological capabilities through Veridix AI will ensure the highest standards of clinical research. "We’re honored to work with ILiAD on BPZE1, which could significantly reduce whooping cough," said Emmes Group CEO, Sastry Chilukuri. Read more about this partnership here: https://lnkd.in/eJzEKCeR #EmmesGroup #ILiADBiotech #BPZE1 #VaccineDevelopment #ClinicalTrials #WhoopingCough

Experience the Emmes difference in clinical trials: https://hubs.la/Q02BJgPw0. Read how through streamlining processes and pursuing multiple workstreams, we launched a study just 12 days after protocol finalization. In a recent Phase II mpox vaccine study, we shortened the startup timeline without compromising quality or patient safety. Our proactive approach and innovative tools ensure we meet sponsor needs with speed and flexibility. #ClinicalTrials #VaccineTrials #Innovation #PatientSafety

Veridix AI is modernizing clinical research. Noble Shore's new blog series discusses how to leverage AI and technology to drive trial efficiency, enhance data quality and ultimately improve patient outcomes. learn more: https://lnkd.in/e-5rArxa #ClinicalResearch #AIinHealthcare #VeridixAI #ClinicalTrials #HealthcareInnovation

Facing pressures in infectious disease and vaccine clinical development? Discover in this eBook https://lnkd.in/eutRWQaZ how implementing these 6 rapid study start-up approaches leads to faster study initiation, reduced timelines, and improved overall clinical trial efficiency. #InfectiousDisease #CROpartner #ClinicalTrials #VaccineResearch #ClinicalDevelopment

Today Is International Clinical Trials Day! For the clinical research industry, May 20 is an important day. It commemorates James Lind’s famous scurvy trial, which began on May 20, 1747, and is considered the first clinical trial. The day is recognized as International Clinical Trials Day to increase awareness about clinical trials, support global dialogue about trials, and celebrate their importance. The Emmes Group is proud of the important work we do advancing global health through clinical trials and grateful for the contributions each team member makes in these efforts. See the infographic below highlighting our contributions or visit https://hubs.la/Q02xKWCV0 to learn more about us. #CRO #ClinicalResearch #InternationalClinicalTrialsDay #Emmes

Emmes is proud to be a partner of Luxa Biotechnology LLC, helping them accelerate clinical trials to deliver innovative treatments and improve patient outcomes. Reach out to our SVP, Global Head of Ophthalmology Nilay Shah and AVP, Scientific Director Ophthalmology Supriya Menezes to learn more about Emmes' ophthalmological services. https://lnkd.in/eppBtHfr #CRO #Emmes #Ophthalmology #ClininicalResearch